Abstract
Periodontitis is an inflammatory disease, in which the host immuno‐inflammatory response against the dysbiotic subgingival biofilm leads to the breakdown of periodontal tissues. Most of the available treatments seem to be effective in the short‐term; nevertheless, permanent periodical controls and patient compliance compromise long‐term success. Different strategies have been proposed for the modulation of the host immune response as potential therapeutic tools to take a better care of most susceptible periodontitis patients, such as drug local delivery approaches. Though, maintaining an effective drug concentration for a prolonged period of time has not been achieved yet. In this context, advanced drug delivery strategies using biodegradable nanocarriers have been proposed to avoid toxicity and frequency‐related problems of treatment. The versatility of distinct nanocarriers allows the improvement of their loading and release capabilities, and could be potentially used for microbiological control, periodontal regeneration, and/or immuno‐modulation. In the present review, we revise and discuss the most frequent biodegradable nanocarrier strategies proposed for the treatment of periodontitis, including polylactic‐co‐glycolic acid (PLGA), chitosan and silica‐derived nanoparticles, and further suggest novel therapeutic strategies.
This article is protected by copyright. All rights reserved.
from OroFacial via a.sfakia on Inoreader https://ift.tt/2LpEjXr
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.